Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12

Hepatology

Volumn 33, Issue 1, 2001, Pages 52-61

  Barajas, M ^a   Mazzolini, G ^a   Genovie G ^a   Bilbao, R ^a   Narvaiza, I ^a   Schmitz, V ^a   Sangro, B ^a   Melero, I ^a   Qian, C ^a   Prieto, J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADCMVIL 12; ANGIOGENESIS INHIBITOR; DIETHYLNITROSAMINE; GAMMA INTERFERON; INTERLEUKIN 12; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035197719     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.20796     Document Type: Article

References (51)

1. Hepatocellular carcinoma
2. Treatment of hepatocellular carcinoma: Too many options?
3. Treatment of hepatocellular carcinoma
4. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
5. Cytokine, tumor-cell death, and immunogenicity: A question of choice
6. Cytokines and gene therapy
7. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells
8. IL-12: A key cytokine in immune regulation
9. Interleukin-12: Cytokines at the interface of inflammation and immunity
10. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
11. Administration of recombinant interleukin-12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes
12. Effect of interleukin 12 on tumor induction by 3-methylcholanthrene
13. Cytokine and chemokine expression in tumors of mice receiving systemic IL-12 therapy
14. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production
15. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: Suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model
16. Inhibition of angiogenesis in vivo by interleukin-12
17. Inhibition of angiogenesis by interleukin-12 is mediated by interferon-inducible protein 10
18. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells
19. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo
20. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo
21. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12
22. Role of interferon-g in IL-12-induced pathology in mice
23. Mechanisms of interleukin 12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids
24. Cytokine gene therapy of cancer using interleukin-12: Murine and clinical trials
25. IL-12 deaths: Explanation and a puzzle
26. High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12
27. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma
28. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12
29. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer
30. In situ cancer vaccination: An IL-12 defective vector/replication-competent HSV combination induces local and systemic antitumor activity
31. Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at distant sites in a murine renal carcinoma model
32. Gene gun-mediated skin transfection with interleukin 12 gen results in regression of established primary and metastatic murine tumors
33. Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma
34. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase
35. Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12
36. Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma
37. Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level
38. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-γ-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy
39. Liver carcinogenesis by diethylnitrosamine in the rat
40. Liver cell control after discontinuation of DENA feeding in hepatocarcinogenesis
41. Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine
42. Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery
43. Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes
44. Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: The role of nitric oxide
45. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector
46. Adenoviral delivery of recombinant DNA into transgenic mice bearing hepatocellular carcinomas
47. In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2
48. In vivo gene therapy of experimental hepatocellular carcinoma using a recombinant defective adenovirus expressing the thymidine-kinase of herpes simplex virus
49. Adenovirus vectors for gene delivery
50. Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice
51. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus